Table Of Contents
1. Introduction 20
1.1. Objectives Of The Study 20
1.2. Market Definition 20
1.3. Overview Of North America Orthopedic Soft Tissue Repair Market 21
1.4. Currency And Pricing 21
1.5. Limitation 21
1.6. Markets Covered 22
2. Market Segmentation 24
2.1. Markets Covered 24
2.2. Geographic Scope 25
2.3. Years Considered For The Study 26
2.4. Currency And Pricing 26
2.5. Research Methodology 27
2.6. Primary Interviews With Key Opinion Leaders 30
2.7. Secondary Sources 31
2.8. Assumptions 31
3. Market Overview 32
3.1. Drivers 34
3.1.1. Increasing Rate Of Accidents And Injuries 34
3.1.2. Growth In The Aging Population 34
3.1.3. Rise In The Healthcare Expenditure 35
3.2. Restraints 35
3.2.1. Lack Of Trained Staff And Professionals 35
3.3. Opportunity 36
3.3.1. Technological Advancements 36
?
3.4. Challenges 36
3.4.1. Increase In The Cost Of Surgical Procedure 36
4. Executive Summary 37
5. Premium Insights 39
6. North America Orthopedic Soft Tissue Repair Market, By Product Type 42
6.1. Overview 43
6.2. Fixation Devices 45
6.2.1.1. Suture Anchors 46
6.2.1.2. Interference Screw 46
6.2.1.3. Other Fixation Devices 46
6.3. Tissue Patch 47
6.3.1. Synthetic Mesh 48
6.3.2. Biological Mesh 48
6.3.2.1. Allograft 49
6.3.2.2. Xenograft 49
6.4. Laparoscopic Instruments 50
7. North America Orthopedic Soft Tissue Repair Market, Procedure 51
7.1. Overview 52
7.2. Anterior Cruciate Ligament (Acl) 54
7.3. Rotator Cuff 55
7.4. Vaginal Prolapse 56
7.5. Lateral Epicondylitis 57
7.6. Achilles 58
7.7. Gluteal Tendon 59
?
8. North America Orthopedic Soft Tissue Repair Market, By End User 60
8.1. Overview 61
8.2. Hospitals 63
8.3. Ambulatory Center 64
8.4. Orthopedic Clinics 65
9. North America Orthopedic Soft Tissue Repair Market, By Geography 66
9.1. Overview 67
9.2. North America 74
9.2.1. U.S. 83
9.2.2. Canada 85
9.2.3. Mexico 87
10. North America Orthopedic Soft Tissue Repair Market,
Company Landscape 189
10.1. Company Share Analysis; North America 190
11. Company Profiles 193
11.1. Medtronic 193
11.1.1. Company Overview 193
11.1.2. Revenue Analysis 193
11.1.3. Product Portfolio 194
11.1.4. Recent Developments 194
11.2. Koninklijke Dsm N.V. 195
11.2.1. Company Overview 195
11.2.2. Revenue Analysis 195
11.2.3. Product Portfolio 196
11.2.4. Recent Developments 196
11.3. Arthrex, Inc. 197
11.3.1. Company Overview 197
11.3.2. Company Snapshot 197
11.3.3. Product Portfolio 198
11.3.4. Recent Developments 199
11.4. Acelity L.P. Inc. 200
11.4.1. Company Overview 200
11.4.2. Company Snapshot 200
11.4.3. Product Portfolio 201
11.4.4. Recent Developments 201
11.5. Zimmer Biomet 202
11.5.1. Company Overview 202
11.5.2. Revenue Analysis 202
11.5.3. Product Portfolio 203
11.5.4. Recent Developments 203
11.6. Stryker 204
11.6.1. Company Overview 204
11.6.2. Revenue Analysis 204
11.6.3. Product Portfolio 205
11.6.4. Recent Developments 205
11.7. Smith & Nephew 206
11.7.1. Company Overview 206
11.7.2. Revenue Analysis 206
11.7.3. Product Portfolio 207
11.7.4. Recent Developments 208
?
11.8. Depuy Synthes (Subsidiary Of Johnson & Johnson
Services, Inc) 209
11.8.1. Company Overview 209
11.8.2. Revenue Analysis 210
11.8.3. Product Portfolio 211
11.8.4. Recent Developments 211
11.9. W. L. Gore & Associates, Inc 212
11.9.1. Company Overview 212
11.9.2. Company Snapshot 212
11.9.3. Product Portfolio 213
11.9.4. Recent Developments 213
11.10. Conmed Corporation 214
11.10.1. Company Overview 214
11.10.2. Revenue Analysis 214
11.10.3. Product Portfolio 215
11.10.4. Recent Developments 215
12. Related Reports 216
?